1-3 of 3
Feiran Gong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bird Regimen Followed By Anti-BCMA CAR T-Cell Immunotherapy As First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 3 Trial

Yue Zhou, Juan Chen, Qingya Cui, Haiping Dai, Zheng Li, Jia Yin, Wei Cui, Mengyun Li, Xuekai Li, Xin Zhang, Feiran Gong, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood
Blood (2024) 144 (Supplement 1): 3384.
https://doi.org/10.1182/blood-2024-199119
Published: 2024
Journal Articles

Combined Infusion of Anti-CD19 and Anti-Bcma CART Cells after Early or Later Transplantation in the Front Line Was Superior to Salvage Therapy for High Risk MM

Xiaolan Shi, Lingzhi Yan, Jingjing Shang, Liqing Kang, Song Jin, Huizhu Kang, Ruju Wang, Zhu Mingqing, Jiazi Zhou, Feiran Gong, Guanghua Chen, Jin Zhou, Huirong Chang, Weiqin Yao, Ying Yao, Yong Liu, Zhi Yan, Juanjuan Su, Depei Wu, MD PhD, Lei Yu, Fu Cheng Cheng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1949.
https://doi.org/10.1182/blood-2019-131546
Published: 2019
Journal Articles

Evaluating Prognostic Value of Patients with Newly Diagnosed Multiple Myeloma By Serum Free Light Chain κ/λ Ratio in Combination with LDH

Chengcheng Fu, Panfeng Wang, Feiran Gong, Jiazi Zhou, Ying Yao, Yun Xu, Yang Xu, Huirong Chang, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5623.
https://doi.org/10.1182/blood.V128.22.5623.5623
Published: 2016